Return to homepagePandemic Pact

COVID Supplement to Terry Beirn CPCRA Clinical Trials Unit

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3UM1AI069503-14S1

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2020

  • Known Financial Commitments (USD)

    $601,947

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    VIRGINIA KAN

  • Research Location

    United States of America

  • Lead Research Institution

    GEORGE WASHINGTON UNIVERSITY

  • Research Priority Alignment

    N/A

  • Research Category

    N/A

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

CPCRA CTU # 60407: Admin Supplement NOT-AI-20-031 & PA-18-591 Principal Investigator: KAN, Virginia L.PROJECT SUMMARY/ABSTRACTThe Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) Clinical Trials Unit (CTU)# 60407 is pleased to submit an Administrative Supplement application in response to NOT-AI-20-031 and PA-18-591 through the George Washington University (GWU), the applicant organization, in collaboration with twoaffiliated Clinical Research Sites (CRSs). This CTU is led by Virginia L. Kan, MD, Principal Investigator.This supplement will provide funding to expand SARS-CoV-2 testing at the following two CTU-affiliated ClinicalResearch Sites:Site 01: George Washington University (GWU) CRS # 31608, Washington, DCSite 02: Houston AIDS Research Team (HART) CRS # 31473, Houston, TX